Heterocyclic compounds and imaging agents for imaging huntingtin protein

Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors

Boron-containing compound and organic light-emitting element comprising same

Compound, liquid crystal composition, cured product, optically anisotropic body, and reflective film

Deuterated melflufen compounds

Deuterated JAK inhibitor and uses thereof

Site-specific isotopic labeling of 1,4-diene systems

PET-IMAGING IMMUNOMODULATORS

PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND

DIHYDROIMIDAZOPYRAZINONE COMPOUND, COMPOSITION INCLUDING SAME, AND USE THEREOF

ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME

Indane derivatives as hypoxia inducible factor-2(α) inhibitors

Deuterated protease inhibitors

Probes for imaging huntingtin protein

Therapeutic solid dosage forms

Heterocyclic compound, light-emitting device including heterocyclic compound, and electronic apparatus including light-emitting device

Compound and organic light emitting diode comprising same

Ibogaine-related compounds and corresponding methods

Inhibitors of kinase networks and uses thereof

Protein kinase inhibitors, preparation method and medical use thereof

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

Compounds useful for inhibiting RET kinase

Deuterated tryptamine derivatives and methods of use

5-azaindazole derivatives as adenosine receptor antagonists

Deuterated RUC-4

Organic electroluminescence device and organometallic compound for organic electroluminescence device

Halogenated Cholesterol Analogues and Methods of Making and Using Same

Positive allosteric modulators of the muscarinic acetylcholine receptor M1

Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof

Deuterated compounds and uses thereof

ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF

NOVEL DEUTERIUM SUBSTITUTED POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS AND THEIR PHARMACOLOGICAL APPLICATION

Composition and methods for tumor imaging and treatment

Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same

RADIOLABELLED COMPOUND OF A QUATERNARY AMMONIUM SALT OF A POLYCYCLIC AROMATIC AMINE AND METHODS OF MANUFACTURING AND DIAGNOSTIC USE THEREOF

Fatty acid derivative labeled with positron-emitting radionuclide

Compounds and their use for the treatment of alpha1-antitrypsin deficiency

SITE-SPECIFIC ISOTOPIC LABELING OF 1,4-DIENE SYSTEMS

PURIFICATION METHOD AND COMPOSITIONS

DEUTERATED DERIVATIVES OF RUXOLITINIB

ISOLITHOCHOLIC ACID OR ISOALLOLITHOCHOLIC ACID AND DEUTERATED DERIVATIVES THEREOF FOR PREVENTING AND TREATING CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASES

COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR

Organometallic compound and organic light-emitting device including the same

Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation

Phenoxytriazoles

Small Molecule Drug Conjugates

Electroluminescent devices

Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof

Deuterated derivatives of lanifibranor

Deuterated (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases

COMPOUNDS USEFUL FOR IN VIVO IMAGING OF PROTEIN OXIDATION AND/OR CANCER TREATMENT

Compounds for treating or inhibiting recurrence of acute myeloid leukemia

DEUTERATED MGL-3196 COMPOUND AND USE THEREOF

METHOD OF FORMING AND SEPARATING TIN(II) FROM TIN(IV)

Organic light-emitting diode having long lifespan, low voltage, and high efficiency property

Compound for organic electric element, organic electric element comprising the same and electronic device thereof

RADIOLABELLED COMPOUND

Diarylpyrazole compound, composition comprising same, and use thereof

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

Hepatitis B antiviral agents

Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as ATR kinase inhibitors

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

Deuterated compounds as immunomodulators

MONO-, DI- OR POLYSACCHARIDE USED AS METAL INHIBITOR IN THE PREPARATION OF 68GA-CHELATE-FUNCTIONALIZED TARGETING AGENT

NOVEL COMPOUND BINDING TO DESIGNER RECEPTOR, IMAGING METHOD FOR DESIGNER RECEPTOR, AGONIST OR ANTAGONIST, THERAPEUTIC AGENT, COMPANION DIAGNOSTIC AGENT, AND IMAGING METHOD FOR NERVE CELL

Click-mass spectrometry of alkyne-labeled compounds

Pyrimidine derivative and preparation process and use thereof

Deuterated EPI-743

Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof

KIT FOR RADIOLABELLING WITH 68GA COMPRISING A METAL INHIBITOR

COMPOUND HAVING BET INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREFOR

NOVEL COMPOUNDS FOR DIAGNOSIS

STABILIZED POLYUNSATURATED COMPOUNDS AND USES THEREOF

Organic electroluminescent materials and devices

MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2

Organic light emitting material

Deuterated Defactinib compound and use thereof

Cyclopropanation method

ACETYLATED PRODRUGS FOR DELIVERY ACROSS THE BLOOD-BRAIN BARRIER

Compounds and probes for imaging huntingtin protein

Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides

Hepatitis B antiviral agents

PROCESS FOR PREPARATION OF ((3R,11BR)-1,3,4,6,7,11B-HEXAHYDRO-9,10-DI(METHOXY-D3)-3-(2-METHYLPROPYL)-2H-BENZO[A]QUINOLIZIN-2-ONE

MONOAMINE OXIDASE B IMAGING PROBE

CANNABINOID DERIVATIVES

IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS)

Compositions and methods for the treatment and imaging of cancer

Compound for organic electric element, organic electric element comprising the same and electronic device thereof

6-AMINOPYRIDIN-3-YL THIAZOLES AS MODULATORS OF RORyT

Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide

Organic electroluminescent materials and devices

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-D3) pyridazine-3-carboxamide

11C-labeled catechol derivative, pet probe of phosphorylated tau aggregation inhibitor using the same, and production method of the same

AURORA KINASE INHIBITORS AND USES THEREOF

6-AMINOPYRIDIN-3-YL THIAZOLES AS MODULATORS OF RORyT

Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereof

Emopamil binding protein binding agent and use thereof

ONE-STEP, FAST, 18F-19F ISOTOPIC EXCHANGE RADIOLABELING OF DIFLUORO-DIOXABORININS AND USE OF SUCH COMPOUNDS IN TREATMENT

6-AMINOPYRIDIN-3-YL THIAZOLES AS MODULATORS OF RORyT

Antagonists of the muscarinic acetylcholine receptor M4

AZA-PYRIDONE COMPOUNDS AND USES THEREOF

Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereof

NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

Compound for organic electronic element, organic electronic element using same and electronic device thereof

Tricyclic compounds

Modulators of alpha-1 antitrypsin

Biochemical binding of RET9 and VEGFR2 inhibitors

Certain aryl pladienolide compounds and methods of use

Oxysterols and methods of use thereof

HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE

Dopamine-b-hydroxylase inhibitors

Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof

Compounds which are inhibitors of Notum

Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Small molecule inhibitors of Ebola and Lassa fever viruses and methods of use

Organic electroluminescence device and organometallic compound for organic electroluminescence device

Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels

Substituted macrocyclic compounds and related methods of treatment

Muscarinic acetylcholine Mreceptor antagonists

LXR modulators with bicyclic core moiety

Analogs of fexaramine and methods of making and using

Method of high-pressure purification of [f-18]FEONM

Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device

COMPOUND AND METHOD FOR THE TREATMENT AND DIAGNOSIS OF NEURODEGENERATIVE CONDITIONS

Macrocyclic compounds as TRK kinases inhibitors

Pyrimidine derivative containing one deuterium atom and preparation process and use thereof

Automatic process platform for the production of astatine-211 [At-211]-radiopharmaceuticals

Radiotracer Derivatives Of Trimethoprim For Diagnostic Imaging

SELECTIVE LIGANDS FOR TAU AGGREGATES

Double targeted constructs to affect tumor kill

PURIFICATION METHOD

Small molecule inhibitors of KRAS G12C mutant

Deuterated analogs of MK2 inhibitors and uses thereof

Compounds, salts thereof and methods for treatment of diseases

Silylations of aromatic substrates with base-activated organosilanes

Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists

Radiolabeled cannabinoid receptor 2 ligand

Radioactive compound for treatment of melanoma and use thereof

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

TSPO binders

A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS

NEUTRON BEAM DYNAMIC THERAPY

Organometallic compound, organic light-emitting device including the same and electronic apparatus including the organic light-emitting device

Development of Imaging and Therapeutic Glucose Analogues for Sodium Dependent Glucose Transporters

Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity

Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereof

Isotopically-stabilized tetronimide compounds

Carboxamides as modulators of sodium channels

POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS

1-STEP RADIOSYNTHESIS OF [18F]SFB

Polycyclic carbamoylpyridone derivatives, pharmaceutical compositions and use thereof

Glucosamine derivatives for the prevention or treatment of joint disorders

N-(2-(substituted-naphth-1-yl)ethyl) substituted amide compound, preparation and uses thereof

Bifunctional cytotoxic agents containing the CTI pharmacophore

Methods for the synthesis of deuterated dextromethorphan

Modulators of cystic fibrosis transmembrane conductance regulator

9H-pyrrolo-dipyridine derivatives

Gamma-carboline compounds for the detection of Tau aggregates

TYK2 inhibitors and uses thereof

Fluorinated beta-hydroxybutyric acids for PET imaging

AZACARBOLINE COMPOUNDS FOR THE DETECTION OF TAU AGGREGATES

Pyridine lactam compounds and methods of use thereof

Compounds useful as inhibitors of ATR kinase

1,2,3-triazole inhibitors of P97 AAA ATPase activity

IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY

Solid phase purification

DEUTERATED sGC STIMULATORS

DEUTERATED sGC STIMULATORS

Radiolabeling of polypeptides

Stabilized radiolabelling reaction

[18F] FMAU LABELING FOR PET IMAGING OF CANCER PATIENTS

ORGANIC COMPOUNDS

Antibacterial agents: soluble salts and aqueous formulations of pyronins

Sulphonyl urea derivatives as NLRP3 inflammasome modulators

Compounds, compositions, and methods

Antibacterial agents: O-alkyl-deuterated pyronins

Creatine prodrugs, compositions and methods of use thereof

Low affinity poly(AD-ribose) polymerase 1 dependent cytotoxic agents

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

Organic light-emitting device and organometallic compound

Organic electroluminescent compounds and organic light emitting devices using the same

Antagonists of the muscarinic acetylcholine receptor M4

Therapeutic compounds

Methods of making deuterium-enriched N-acetylcysteine amide (d-NACA) and (2R, 2R′)-3,3′-disulfanediyl bis(2-acetamidopropanamide) (diNACA) and using d-NACA and diNACA to treat diseases involving oxidative stress

4-hydroxybutyric acid analogs

Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same

Inhibitors of APOL1 and methods of using same

METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE

Imaging Agents

COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF

Process for deoxyfluorination of phenols

Production method for radiolabeled aryl compound

MORPHINAN DERIVATIVES AND USE THEREOF

DEUTERATED INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION THEREOF

RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER

Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2

METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors

METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS

Cyclic peroxides as prodrugs for selective delivery of agents

Methods for the synthesis of deuterated dextromethorphan

Compositions And Methods For Imaging Immune Cells

Proteasome activity enhancing compounds

Inhibitors of kinase networks and uses thereof

Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders

Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer

Bicyclic compounds for diagnosis and therapy

COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE

Deuterated compounds

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

PCSK9 inhibitors and methods of use thereof

Deuterium-Substituted Pyridin- And Pyrimidin-2-yl-Methylamine Compounds

Processes for making modulators of cystic fibrosis transmembrane conductance regulator

Deuterated CFTR potentiators

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

Stable isotope-labeled compounds

Bicyclic compounds for use as RIP1 kinase inhibitors

Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

KDM1A inhibitors for the treatment of disease

PSMA-BINDING AGENTS AND USES THEREOF

Precursor compound of radioactive halogen-labeled organic compound

Substituted bicyclic compounds

Deuterium Atom-Substituted Indole Formamide Derivative, Preparation Method Therefor, and Medical Applications Thereof

Deuterated fezolinetant

Esters of dihydrotetrabenazine

Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide

Deuterated compounds and uses thereof

DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME

Benzoimidazole indolyl methanes and methods of using them to inhibit PCKS9 and PCKS9-mediated ailments

Isotopically-stabilized tetronimide compounds

Hyperpolarized and deuterium exchanged hyperpolarizedC and N-labeled xanthine, arginine, glutamine, and urea probes

6-Substituted 3-Fluoro-2-Pyridinaldoxime, 3-Fluoro-2-pyridine hydroxamic acid, and 3-Fluoro-2-Pyridinamidoxime scaffolds

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

5-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

Method of High-Pressure Purification of [F-18]FEONM

Method for synthesizing iodo- or astatoarenes using diaryliodonium salts

Microfluidic cassette for synthesizing a radio-tracer and method of synthesizing a radio-tracer with such a cassette

PSMA TARGETED RADIOHALOGENATED UREAS FOR CANCER RADIOTHERAPY

Inhibitors of lysine specific demethylase-1

Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents

Compositions, methods, and systems for the synthesis and use of imaging agents

Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application

Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof

Derivatives of Resiquimod

Hepatitis B antiviral agents

Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Deuterated compounds and uses thereof

DICARBOXYLIC FATTY ACID DIMERS, AND DERIVATIVES THEREOF, AS STANDARDS FOR QUANTIFYING LEVELS IN BIOSPECIMENS

Compounds and methods for DCAF-mediated protein degradation

Substituted heteroaryl compound, composition containing same, and application thereof

Process for the preparation of deuterated ethanol from D2

Deuterated agonists and methods of use

Deuterium-enriched pioglitazone

Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity

Compounds useful as imaging agents of hypoxia

Isotopically labeled bile acid derivatives

Protein kinase inhibitors, preparation method and medical use thereof

Precursors for radiofluorination

Process for the preparation of deuterated ethanol from DO

Crystal form of deuterated AZD9291, preparation method therefor, and use thereof

Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

Indazole compound for use in inhibiting kinase activity, composition and application thereof

Inhibitors of CXCR2

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Radioactive labeled long-acting peptide targeted pharmaceutical and production method thereof

Cot modulators and methods of use thereof

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

Protein kinase inhibitors

DEUTERATED CFTR MODULATORS AND METHODS OF USE

Analogs of fexaramine and methods of making and using

Compositions and methods for inhibition of the JAK pathway

Modulators of ATP-binding cassette transporters

Organic electroluminescence device and electronic apparatus provided with the same

Site-specific isotopic labeling of 1,4-diene systems

Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

METHOD FOR PREPARING DEUTERATED IMIDAZOLE DIKETONE COMPOUND

Organic electroluminescent materials and devices

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Diphenylaminopyrimidine compound for inhibiting kinase activity

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

Process for producing flutametamol

Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity

HDAC6 inhibitors and imaging agents

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

Heterocyclic derivatives and their use in the treatment of neurological disorders

Solid phase conditioning

Closed evaporation system

Deuterated N-(5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)-2-fluorophenyl)-2-((4-ethylpiperazin-1-yl)methyl)quinoline-6-carboxamide

Voltage gated sodium channel imaging agents